Table 2. Distribution of data by gender, outliers and the final number of samples used to estimate RIs.
As determined by the Kolmogorov-Smirnov normality test<br>+ Values that do not meet normality, p <0.05<br>* Values that meet normality, p >0.05<br># Values obtained using the Friedewald equation
| Male | Female | |||||
|---|---|---|---|---|---|---|
| Parameter | Normality | Atypical<br>values | Final data<br>number | Normality | Atypical<br>values | Final data<br>number |
| Glucose | <0.0001+ | 43 | 492 | 0.0302+ | 16 | 584 |
| Urea | 0.0545* | 10 | 526 | 0.0286+ | 10 | 590 |
| AST | <0.0001+ | 23 | 502 | >0.1000* | 11 | 589 |
| ALT | >0.1000* | 6 | 518 | >0.1000* | 5 | 595 |
| Alkaline phosphatase | 0.0963* | 7 | 527 | 0.0002+ | 15 | 585 |
| Total Bilirubin | 0.0337+ | 9 | 516 | >0.1000* | 9 | 591 |
| Direct Bilirubin | 0.0251+ | 7 | 514 | <0.0001+ | 21 | 579 |
| Uric acid | 0.0005+ | 13 | 517 | 0.0012+ | 6 | 594 |
| LDL Cholesterol | >0.1000* | 6 | 501 | >0.1000* | 4 | 596 |
| HDL Cholesterol | >0.1000* | 5 | 538 | >0.1000* | 8 | 592 |
| VLDL# Cholesterol | <0.0001+ | 0 | 511 | <0.0001+ | 0 | 599 |
| Total Cholesterol | <0.0001+ | 18 | 525 | >0.1000* | 7 | 593 |
| Triglycerides | <0.0001+ | 20 | 511 | >0.1000* | 1 | 599 |
| Total Proteins | 0.0116+ | 6 | 502 | 0.0012+ | 2 | 598 |
| AST/ALT | <0.0001+ | 4 | 519 | <0.0001+ | 8 | 592 |
| FIB-4 | <0.0001+ | 0 | 523 | <0.0001+ | 5 | 595 |
| Apri index | <0.0001+ | 25 | 498 | <0.0001+ | 16 | 584 |